References
- Mucke L. Neuroscience: Alzheimer's disease. Nature 2009;461:895–7.
- Palotas A, Kalman J. Candidate susceptibility genes in Alzheimer's disease are at high risk for being forgotten— they don't give peace of mind. Curr Drug Metab 2006;7:273–93.
- Antoniades D, Datopodi T, Pappa S, et al. The role of reelin gene polymorphisms in the pathogenesis of Alzheimer's disease in a Greek population. J Biol Regul Homeost Agents 2011;25:351–8.
- Wang LZ, Tian Y, Yu JT, et al. Association between late-onset Alzheimer's disease and microsatellite polymorphisms in intron II of the human toll-like receptor 2 gene. Neurosci Lett 2011;489:164–7.
- Yu JT, Sun YP, Ou JR, et al. No association of toll-like receptor 2 polymorphisms with Alzheimer's disease in Han Chinese. Neurobiol Aging 2011;32:1924 e1921–1923.
- Bertram L, Tanzi RE. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 2008;9:768–78.
- Roses AD. Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases. Am J Med Genet 1998;81:49–57.
- Kapranov P, Cheng J, Dike S, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007;316:1484–8.
- Brosnan CA, Voinnet O. The long and the short of noncoding RNAs. Curr Opin Cell Biol 2009;21:416–25.
- Faghihi MA, Modarresi F, Khalil AM, et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008;14:723–30.
- Lukiw WJ, Handley P, Wong L, et al. BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD). Neurochem Res 1992;17:591–7.
- Massone S, Vassallo I, Fiorino G, et al. 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis 2011;41:308–17.
- Chen G, Qiu C, Zhang Q, et al. Genome-wide analysis of human SNPs at long intergenic noncoding RNAs. Hum Mutat 2013;34:338–44.
- Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–92.
- Jin C, Zhang Y, Wang J, et al. Lack of association between MPC2 variants and schizophrenia in a replication study of Han Chinese. Neurosci Lett 2013;552:120–3.
- Shi Y, Li Z, Xu Q, et al. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat Genet 2011;43:1224–7.
- Yuan J, Jin C, Qin HD, et al. Replication study confirms link between TSPAN18 mutation and schizophrenia in Han Chinese. PLoS One 2013;8:e58785.
- Faul F, Erdfelder E, Lang AG, et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175–91.
- Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009;136:629–41.
- Jin G, Sun J, Isaacs SD, et al. Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carcinogenesis 2011;32:1655–9.
- Verhaegh GW, Verkleij L, Vermeulen SH, et al. Polymorphisms in the H19 gene and the risk of bladder cancer. Eur Urol 2008;54:1118–26.
- Yuan E, Li CM, Yamashiro DJ, et al. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms’ tumors. Mol Cancer Res 2005;3:493–502.